Sawai Group Holdings, headquartered in Japan, is a leading pharmaceutical group specializing in the development and production of high-quality generic drugs. The company makes an essential contribution to global healthcare by providing affordable, safe, and effective pharmaceutical products worldwide.
Date confirmed from the Tokyo Stock Exchange (JPX) announcement schedule.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Sawai Group Holdings is scheduled to report its next quarterly earnings on 11/13/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Sawai Group Holdings last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at 21.04 JPY.
Across its last 3 earnings reports, Sawai Group Holdings stock moved by ±3.4% on average the following day. The largest reaction was -4.6% on 02/13/2026; 0 of 3 reactions were positive.
Sawai Group Holdings has beaten analyst EPS estimates in 0 of its last 5 evaluated quarters (beat rate: 0%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.